Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia

	Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia
	Zhou, Guangbiao ; Hu, Zheng ; Pan, Xiaofen ; Liu, Jinglei ; Ma, Liyuan ; Liu, Xiaoli ; Meng, Fanyi ; Li, Juan ; Chen, Zhu ; Chen, Saijuan
刊名	BLOOD
	2007
卷号	110 期号:11 页码:214B-214B
ISSN号	0006-4971
学科主题	Hematology
语种	英语
公开日期	2016-12-16
内容类型	期刊论文
源URL	[http://ir.gibh.ac.cn/handle/344009/629]
专题	广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文
推荐引用方式 GB/T 7714	Zhou, Guangbiao,Hu, Zheng,Pan, Xiaofen,et al. Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia[J]. BLOOD,2007,110(11):214B-214B.
APA	Zhou, Guangbiao.,Hu, Zheng.,Pan, Xiaofen.,Liu, Jinglei.,Ma, Liyuan.,...&Chen, Saijuan.(2007).Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia.BLOOD,110(11),214B-214B.
MLA	Zhou, Guangbiao,et al."Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia".BLOOD 110.11(2007):214B-214B.